T. Rowe Price Associates
ETRM

T. Rowe Price Associates’s EnteroMedics Inc. ETRM Stock Holding History

T. Rowe Price Associates’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,674
Closed -$1.09M – 2611
2015
Q2 		$1.09M Sell
1,674
-2,190
-57% -$2.52M ﹤0.01% 1722
2015
Q1 		$3.71M Sell
3,864
-36
-0.9% -$43.4K ﹤0.01% 1505
2014
Q4 		$5.82M Hold
3,900
– – ﹤0.01% 1438
2014
Q3 		$5.04M Buy
3,900
+39
+1% +$57.2K ﹤0.01% 1453
2014
Q2 		$6.33M Sell
3,861
-5
-0.1% -$9.35K ﹤0.01% 1417
2014
Q1 		$7.39M Buy
3,866
+4
+0.1% +$9.47K ﹤0.01% 1365
2013
Q4 		$8.27M Sell
3,862
-19
-0.5% -$30.6K ﹤0.01% 1338
2013
Q3 		$5.09M Hold
3,881
– – ﹤0.01% 1423
2013
Q2 		$4.64M Buy
+3,881
New +$4.1M ﹤0.01% 1420

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's ETRM Position: Q3 2015 in Review

T. Rowe Price Associates sold out of EnteroMedics Inc. (ETRM) in Q3 2015, closing a stake of 1,674 shares — an estimated $1.09M sold.

T. Rowe Price Associates first reported a position in ETRM in Q2 2013 and held it in 9 quarters. The position peaked at $8.27M in Q4 2013. 41 funds tracked by Wall St. Rank hold ETRM as of Q3 2015.

  • T. Rowe Price Associates reported no remaining EnteroMedics Inc. position as of Q3 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,674 EnteroMedics Inc. shares in Q3 2015, an estimated $1.09M.
  • T. Rowe Price Associates first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 9 quarters.
  • T. Rowe Price Associates's EnteroMedics Inc. position peaked at $8.27M in Q4 2013.
  • 41 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2015.

Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.